PGR Isoform modulation via enhancer activation regulates progesterone signaling in endometrial stromal cells.

F S Sci

Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, 27709, United States. Electronic address:

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To investigate enhancer-mediated regulation of progesterone receptor (PGR) isoforms, PGR-A and PGR-B, in human endometrial stromal cells, and to determine how isoform modulation shapes the progesterone-responsive transcriptome and cistrome relevant to endometrial function.

Design: A CRISPR-based functional genomic screen was used to identify distal enhancers in telomerase-immortalized human endometrial stromal cells. Subsequent CRISPR targeting of identified enhancers and the PGR promoter was used to modulate PGR isoform balance and assess functional consequences.

Subjects: None.

Exposure: Engineered endometrial stromal cells were treated with medroxyprogesterone acetate (MPA) or vehicle.

Main Outcome Measures: PGR isoform expression was assessed by western blot, the progesterone-responsive transcriptome was characterized by bulk RNA sequencing, and the PGR cistrome was characterized by Cut&Run.

Results: Two distal PGR enhancers were identified in endometrial stromal cells located approximately 60 and 220 kb upstream of the PGR transcription start site. CRISPR-based activation of these enhancers upregulated both PGR-A and PGR-B, while promoter activation primarily upregulated PGR-B. Bulk RNA sequencing revealed that shifting the PGR isoform balance altered the progesterone-regulated transcriptome: PGR-A/B-equivalent cells exhibited pro-inflammatory gene signatures, while PGR-B-dominant cells demonstrated suppression of inflammatory signaling and altered cell cycle programs. PGR Cut&Run profiling revealed distinct genomic binding patterns associated with each isoform profile. Integration of the PGR cistrome with chromatin interaction maps suggested that these isoforms directly regulate distinct gene subsets involved in inflammation and fibrosis. Mechanistically, ESR1 indirectly activated PGR-A expression, potentially through recruitment of FOXO1 at the distal enhancer, suggesting a non-canonical, enhancer-mediated mechanism of PGR regulation.

Conclusions: Distal enhancers regulate the PGR isoform balance and shape the progesterone-responsive transcriptome in human endometrial stromal cells. This enhancer-mediated mechanism expands current models of PGR regulation beyond promoter-level control and may offer potential therapeutic targets to restore normal progesterone responsiveness in conditions marked by PGR isoform imbalance.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.xfss.2025.08.004DOI Listing

Publication Analysis

Top Keywords

pgr isoform
24
endometrial stromal
24
stromal cells
24
pgr
15
human endometrial
12
progesterone-responsive transcriptome
12
isoform balance
12
isoform modulation
8
cells
8
pgr-a pgr-b
8

Similar Publications

PGR Isoform modulation via enhancer activation regulates progesterone signaling in endometrial stromal cells.

F S Sci

August 2025

Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, 27709, United States. Electronic address:

Objective: To investigate enhancer-mediated regulation of progesterone receptor (PGR) isoforms, PGR-A and PGR-B, in human endometrial stromal cells, and to determine how isoform modulation shapes the progesterone-responsive transcriptome and cistrome relevant to endometrial function.

Design: A CRISPR-based functional genomic screen was used to identify distal enhancers in telomerase-immortalized human endometrial stromal cells. Subsequent CRISPR targeting of identified enhancers and the PGR promoter was used to modulate PGR isoform balance and assess functional consequences.

View Article and Find Full Text PDF

Exposure to progesterone is a recognized risk factor for breast cancer, and polymorphisms are associated with various malignancies. Two progesterone receptor (PR) isoforms, full length PR-B and truncated PR-A, are expressed from the gene in breast tissue and play crucial roles in normal physiology and breast cancer progression. An imbalance in the expression ratio of these isoforms, favoring increased levels of PR-A, is common in breast cancer and is associated with resistance to tamoxifen in luminal A-type tumors.

View Article and Find Full Text PDF

The nuclear steroid hormone receptor progesterone receptor (PGR) is expressed in granulosa cells in the ovarian follicle in a tightly regulated pattern in response to the surge of luteinizing hormone (LH) that stimulates ovulation. PGR plays a critical role in mediating ovulation in response to LH, however, the mechanism for this is still unknown. We performed immunoprecipitation-mass spectrometry using the KGN human granulosa cell line expressing the primary PGR isoforms PGR-A or PGR-B, to identify novel interacting proteins that regulate PGR function in these ovary-specific target cells.

View Article and Find Full Text PDF

Implantation is a complex process requiring a prepared, receptive endometrium, reliant on synchronized decidualization of stromal cells. During this process, cell proliferation and apoptosis are tightly regulated by signaling factors, including the survival and proliferation of the PI3K/AKT pathway. The three AKT isoforms each play distinct physiological roles, but their specific functions in endometrial cell survival and apoptosis remain unclear.

View Article and Find Full Text PDF

This study aimed to evaluate the histopathological and molecular effects of subcutaneous melatonin implants on the reproductive organs of female cats. Twenty cats were randomly divided into two groups: a control group (Cont), which underwent ovariohysterectomy without prior treatment, and a melatonin-treated group (Mel), which received 18 mg melatonin implants subcutaneously in the interscapular region before ovariohysterectomy. Histopathological and immunohistochemical analyses of uterine tissues were performed, along with quantitative RT-PCR and Western blot to assess inflammatory markers and progesterone receptor expression.

View Article and Find Full Text PDF